# EDGAR Filing Document

**Accession Number:** 0001388325
**File Stem:** 0001104659-25-085700
**Filing Date:** 2025-8
**Character Count:** 12042
**Document Hash:** 04f355c5617b789251f0c8b588f1f09c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-25-085700.hdr.sgml**: 20250829

**ACCESSION NUMBER**: 0001104659-25-085700

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250829

**EFFECTIVENESS DATE**: 20250829

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Novo Holdings A/S
- **CENTRAL INDEX KEY:** 0001388325

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** G7
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-16231
- **FILM NUMBER:** 251281160

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** TUBORG HAVNEVEJ 19
- **CITY:** HELLERUP
- **PROVINCE COUNTRY:** G7
- **ZIP:** 2900
- **BUSINESS PHONE:** 45 8824 8824

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** TUBORG HAVNEVEJ 19
- **CITY:** HELLERUP
- **PROVINCE COUNTRY:** G7
- **ZIP:** 2900

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Novo A/S
- **DATE OF NAME CHANGE:** 20070130

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0001388325

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** Novo Holdings A/S

**Address:** Tuborg Havnevej 19, Hellerup, G7 DK-2900

**Telephone number:** 45-3527-6592

**Name of agent for service:** —

**Agent Address:** —, —, — —

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 028-16231

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** —

**Report Type (check only one):**

Institutional Manager.

- [x] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [ ] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 0

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER                  | CUSIP     | MEETING DATE   | VOTE DESCRIPTION                                                                                                                                                                                                                         | VOTE CATEGORY                |   SHARES VOTED |   SHARES ON LOAN | HOW VOTED   |   SHARES VOTED FOR OR AGAINST MANAGEMENT | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|---:|:---|:---|
| 4D Molecular Therapeutics, Inc. | 35104E100 | 06/17/2025     | Approval, on an advisory, non-binding basis, of the compensation of the Company's named executive officers ("say-on-pay vote").                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |        2000000 |                0 | FOR         |                                  2000000 | FOR                         |  |
| 4D Molecular Therapeutics, Inc. | 35104E100 | 06/17/2025     | Approval, on an advisory, non-binding basis, of the frequency of future advisory say-on-pay votes.                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |        2000000 |                0 | 1 YEAR      |                                  2000000 | FOR                         |  |
| AbCellera Biologics Inc.        | 00288U106 | 06/12/2025     | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers, or Say on Pay.                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |        1126915 |                0 | FOR         |                                  1126915 | FOR                         |  |
| Amicus Therapeutics, Inc.       | 03152W109 | 06/05/2025     | Approval, on an advisory basis, the Company's executive compensation.                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |        2829626 |                0 | FOR         |                                  2829626 | FOR                         |  |
| Biomarin Pharmaceutical Inc.    | 09061G101 | 05/20/2025     | To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement.                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |         490000 |                0 | FOR         |                                   490000 | FOR                         |  |
| Blueprint Medicines Corporation | 09627Y109 | 06/18/2025     | Approval of a non-binding advisory vote on the compensation paid to our named executive officers.                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |         264956 |                0 | FOR         |                                   264956 | FOR                         |  |
| Crinetics Pharmaceuticals, Inc. | 22663K107 | 06/11/2025     | To consider and vote upon, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission. | SECTION 14A SAY-ON-PAY VOTES |        1275000 |                0 | FOR         |                                  1275000 | FOR                         |  |
| Celldex Therapeutics, Inc.      | 15117B202 | 06/05/2025     | To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement.                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |        1200000 |                0 | FOR         |                                  1200000 | FOR                         |  |
| Edgewise Therapeutics, Inc.     | 28036F105 | 06/13/2025     | Conduct an advisory vote on the compensation of our named executive officers.                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |        5350000 |                0 | FOR         |                                  5350000 | FOR                         |  |
| Edgewise Therapeutics, Inc.     | 28036F105 | 06/13/2025     | Conduct an advisory vote on the frequency of future advisory votes on the compensation of our named executive officers.                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |        5350000 |                0 | 1 YEAR      |                                  5350000 | FOR                         |  |
| Insmed Incorporated             | 457669307 | 05/15/2025     | An advisory vote on the 2024 compensation of our named executive officers.                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |         724666 |                0 | FOR         |                                   724666 | FOR                         |  |
| Marqeta, Inc.                   | 57142B104 | 06/12/2025     | To approve, on a non-binding advisory basis, the compensation of our named executive officers.                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |         441558 |                0 | FOR         |                                   441558 | FOR                         |  |
| Mirum Pharmaceuticals, Inc.     | 604749101 | 05/29/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |        1500000 |                0 | FOR         |                                  1500000 | FOR                         |  |
| Recursion Pharmaceuticals, Inc. | 75629V104 | 06/18/2025     | Advisory vote to approve executive compensation as disclosed in the 2025 Proxy Statement.                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |        9665128 |                0 | FOR         |                                  9665128 | FOR                         |  |
| Rocket Pharmaceuticals, Inc.    | 77313F106 | 06/18/2025     | Consider and act upon a non-binding, advisory vote on the compensation of our named executive officers.                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |        1100000 |                0 | FOR         |                                  1100000 | FOR                         |  |
| Salesforce, Inc.                | 79466L302 | 06/05/2025     | Approval, on an advisory basis, of the fiscal 2025 compensation of our named executive officers.                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |         330187 |                0 | FOR         |                                   330187 | FOR                         |  |
| Vaxcyte, Inc.                   | 92243G108 | 06/12/2025     | Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |         916160 |                0 | FOR         |                                   916160 | FOR                         |  |
| Verve Therapeutics, Inc.        | 92539P101 | 06/05/2025     | Approval, on an advisory basis, of the compensation paid to our named executive officers.                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |        3170000 |                0 | FOR         |                                  3170000 | FOR                         |  |
| Viridian Thereaputics, Inc.     | 92790C104 | 06/20/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers.                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |        2327640 |                0 | FOR         |                                  2327640 | FOR                         |  |

## N-PX: Signature Block

**Reporting Person:** Novo Holdings A/S

**By (Signature):** Barbara Fiorini

**By (Printed Signature):** Barbara Fiorini

**By (Title):** General Counsel, Finance  Operations

**Date:** 08/29/2025